Citation Impact
Citing Papers
Quantitation of nitric oxide using 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO)
1996
Screening for Depressive Symptoms Among HCV-Infected Injection Drug Users: Examination of the Utility of the CES-D and the Beck Depression Inventory
2004
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C
2007
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
2009
Antiepileptic drugs: indications other than epilepsy
2004
Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH
1999
Preventing Relapse of Major Depression During Interferon-α Therapy for Hepatitis C—A Pilot Study
2007
Diagnosis, management, and treatment of hepatitis C†
2004
Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users
2004
Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression
2008
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Early prediction of major depression in chronic hepatitis C patients during peg-interferon α-2b treatment by assessment of vegetative-depressive symptoms after four weeks
2007
The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway
2004 StandoutNobel
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
The Rebirth of Neuroscience in Psychosomatic Medicine, Part I: Historical Context, Methods, and Relevant Basic Science
2009
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface
2008
The Failing Heart — An Engine Out of Fuel
2007 Standout
Pro‐inflammatory cytokines and depression in a familial cancer registry
2006
Neuropsychiatric Adverse Effects of Interferon-??
2005
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Role of Nitric Oxide in Pathogenesis of Herpes Simplex Virus Encephalitis in Rats
1999
Disgust as a disease-avoidance mechanism.
2009 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
2015
A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
2013
Pharmacology and therapeutic potential of interferons
2012
Nonresolving Inflammation
2010 Standout
Mood Alterations During Interferon-Alfa Therapy in Patients With Chronic Hepatitis C
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression
2007
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
2017
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection
2014
Treating viral hepatitis C: efficacy, side effects, and complications
2006
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
2011
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Hepatitis C reinfection after sustained virological response
2016
Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis
2005
Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions
1997
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Cytokines as mediators of depression: What can we learn from animal studies?
2005
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Treatment of hepatitis C
2005
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
Major Depressive Disorder
2008 Standout
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
2006
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
2008
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
2007
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
2005
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
The molecular neurobiology of depression
2008 StandoutNature
Illness-related stigma, mood and adjustment to illness in persons with hepatitis C
2006
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
The Role of Inflammation in the Pathophysiology of Depression: Different Treatments and Their Effects
2011
Nitric oxide and virus infection
2000
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Replication of hepatitis C virus
2007 StandoutNobel
Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice
1998 StandoutNobel
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Fiber‐Based Wearable Electronics: A Review of Materials, Fabrication, Devices, and Applications
2014 Standout
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
2014
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
1998
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships
2010
Mechanisms and Models in Heart Failure
2005
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
1997
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.
1996
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Does Nitric Oxide Play a Critical Role in Viral Infections?
1998
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
2007 StandoutNobel
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Martin Schaefer being referenced
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
2004
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
2012
Endoventrikuläre Patchplastik bei Patienten mit idiopathischer, dilatativer Kardiomyopathie eine Alternative zur Herztransplantation?
2001
Recommendations for the management of hepatitis C virus infection among people who inject drugs
2015
The Δ32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-α and ribavirin
2003
Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study
2005
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
2003
Administration of Interferon-Alpha in Mice Provokes Peripheral and Central Modulation of Immune Cells, Accompanied by Behavioral Effects
2008
Interferon alpha (IFNα) and psychiatric syndromes
2002
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism
2003
Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin
2007
Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects
2008
Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design
2001
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α
2004
Neurotransmitter Changes by Interferon-Alpha and Therapeutic Implications
2003
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C
2005
Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain
1995
Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant Melanoma
2010